Breath contains the molecular truth of the body. OSCAii decodes it — in real time, at the precision medicine frontier.
A single exhaled breath contains hundreds of volatile organic compounds spanning orders of magnitude in concentration — a faithful mirror of metabolic state, and a data frontier that existing technologies have long struggled to tame.
Second-level spectral acquisition. No chromatographic separation. No sample preprocessing.
Hundreds of VOCs captured simultaneously across the full molecular fingerprint region in a single measurement.
Isomer-distinguishing resolution. Near shot-noise-limited detection. Exceptional dynamic range.
| Dimension | OSCAii | GC-MS | PTR-MS | FAIMS | Chemical Sensors |
|---|---|---|---|---|---|
| Real-Time Detection | ✓ Seconds | ✗ 72h | ✓ | ✓ | ✓ |
| No Sample Prep | ✓ | ✗ | ✓ | ✓ | ✓ |
| Isomer Discrimination | ✓ | ✓ | ✗ | ✗ | ✗ |
| VOC Coverage | Broadband | Wide | Limited | Narrow | Very Narrow |
| Spectral Resolution | ~100 MHz | ~3 GHz | ~30 GHz | ~300 GHz | Non-specific |
| Quantification | Absolute | Absolute | Relative | Relative | Qualitative |
| No Ionization Required | ✓ | ✗ | ✗ | ✗ | ✓ |
The future of diagnostics is non-invasive, continuous, and molecular. OSCAii is building the platform infrastructure for that future — starting from the physics up.
We are not adapting existing tools. We are establishing a new sensing modality for life science and medicine.
Every claim is grounded in physical experiment. These are snapshots from our active development environment — not renders, not simulations.
OSCAii's platform unlocks new possibilities across drug research, early detection, and continuous clinical monitoring.
The body's molecular landscape shifts constantly — absorbing, transforming, and eliminating compounds across timescales of minutes to hours. OSCAii captures these dynamics non-invasively through breath, providing a real-time window into molecular processes that were previously invisible without repeated sampling.
Disease leaves molecular traces long before clinical symptoms emerge. OSCAii's broadband spectral fingerprinting identifies subtle shifts in exhaled volatile profiles — opening a path toward earlier, non-invasive detection across metabolic and respiratory conditions.
From single-point diagnosis to continuous molecular surveillance. OSCAii transforms breath into a dynamic data stream — enabling longitudinal tracking of disease progression, treatment response, and individual metabolic variability over time.
OSCAii is infrastructure, not just an instrument. Built on dual-comb spectroscopy and electro-optic sampling, the platform is designed to scale across disease areas, research environments, and clinical deployment — with ML-assisted analytics at its core.
We are seeking partners who share our conviction that breath holds the key to a new era of molecular insight.
Those who understand the long-cycle value of deep technology and are willing to co-build a platform-level company from the ground up.
Research institutions and companies with frontier needs in molecular detection — spanning life sciences, drug development, and precision medicine.
Teams with professional laboratory conditions, advancing molecular analysis in real-world clinical settings.
Universities and institutions in spectroscopy, photonics, respiratory medicine, and analytical chemistry.
Have questions or want to explore a partnership? Fill in the form and we'll be in touch.